Filing Details
- Accession Number:
- 0001209191-20-064961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-23 09:12:12
- Reporting Period:
- 2020-12-21
- Accepted Time:
- 2020-12-23 09:12:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178253 | Scynexis Inc | SCYX | Pharmaceutical Preparations (2834) | 562181648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1797160 | Philippe Brian Tinmouth | 1 Evertrust Plaza, 13Th Floor Jersey City NJ 07302 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-21 | 8,000 | $6.25 | 8,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrant | Acquisiton | 2020-12-21 | 4,000 | $0.00 | 4,000 | $7.33 |
| Common Stock | Common Stock Warrant | Acquisiton | 2020-12-21 | 4,000 | $0.00 | 4,000 | $8.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2020-12-21 | 2021-12-21 | No | 4 | A | Direct |
| 4,000 | 2020-12-21 | 2024-06-21 | No | 4 | A | Direct |
Footnotes
- Reflects the purchase on December 21, 2020 of 8,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant).
Billionaire Hedge Funds
